These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8531833)
1. Carbamylation of proteins and atherogenesis in renal failure. Roxborough HE; Young IS Med Hypotheses; 1995 Aug; 45(2):125-8. PubMed ID: 8531833 [TBL] [Abstract][Full Text] [Related]
2. New evidence to support the clinical and biological relevance of the protein carbamylation process in human pathophysiology. Jaisson S; Garnotel R; Gillery P Med Hypotheses; 2008; 70(5):1070-1. PubMed ID: 18179875 [No Abstract] [Full Text] [Related]
3. Carbamylation inhibits the ferroxidase activity of caeruloplasmin. Roxborough HE; Millar CA; McEneny J; Young IS Biochem Biophys Res Commun; 1995 Sep; 214(3):1073-8. PubMed ID: 7575512 [TBL] [Abstract][Full Text] [Related]
4. [Carbamylation of proteins--mechanism, causes and consequences]. Pieniążek A; Gwoździński K Postepy Hig Med Dosw (Online); 2016 May; 70():514-21. PubMed ID: 27180968 [TBL] [Abstract][Full Text] [Related]
5. Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis. Jaisson S; Pietrement C; Gillery P Clin Chem; 2011 Nov; 57(11):1499-505. PubMed ID: 21768218 [TBL] [Abstract][Full Text] [Related]
8. Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Ok E; Basnakian AG; Apostolov EO; Barri YM; Shah SV Kidney Int; 2005 Jul; 68(1):173-8. PubMed ID: 15954906 [TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of low density lipoprotein carbamylation by vitamins, as an ameliorating atherosclerotic risk in uremic patients. Ghaffari MA; Shanaki M Scand J Clin Lab Invest; 2010 Apr; 70(2):122-7. PubMed ID: 20156036 [TBL] [Abstract][Full Text] [Related]
10. [Protein carbamylation: what it is and why it concerns nephrologists]. De Simone E; Di Micco L; La Manna G; Di Iorio B G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786184 [TBL] [Abstract][Full Text] [Related]
11. Impact of fibrinogen carbamylation on fibrin clot formation and stability. Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370 [TBL] [Abstract][Full Text] [Related]
12. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis. Hasselwander O; McEneny J; McMaster D; Fogarty DG; Nicholls DP; Maxwell AP; Young IS Atherosclerosis; 1999 Mar; 143(1):125-33. PubMed ID: 10208487 [TBL] [Abstract][Full Text] [Related]
13. Protein Carbamylation in Chronic Kidney Disease and Dialysis. Long J; Vela Parada X; Kalim S Adv Clin Chem; 2018; 87():37-67. PubMed ID: 30342712 [TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase-catalyzed oxidation of cyanide to cyanate: A potential carbamylation route involved in the formation of atherosclerotic plaques? Delporte C; Zouaoui Boudjeltia K; Furtmüller PG; Maki RA; Dieu M; Noyon C; Soudi M; Dufour D; Coremans C; Nuyens V; Reye F; Rousseau A; Raes M; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J; Robaye B; Vanhamme L; Reynolds WF; Obinger C; Van Antwerpen P J Biol Chem; 2018 Apr; 293(17):6374-6386. PubMed ID: 29496995 [TBL] [Abstract][Full Text] [Related]
15. Protein carbamylation in kidney disease: pathogenesis and clinical implications. Kalim S; Karumanchi SA; Thadhani RI; Berg AH Am J Kidney Dis; 2014 Nov; 64(5):793-803. PubMed ID: 25037561 [TBL] [Abstract][Full Text] [Related]
17. Cyanate as a hemolytic factor. Mun KC; Kim HC; Kwak CS Ren Fail; 2000 Nov; 22(6):809-14. PubMed ID: 11104168 [TBL] [Abstract][Full Text] [Related]
18. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins. Aviram M Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155 [TBL] [Abstract][Full Text] [Related]
19. Role of oxidative modifications in atherosclerosis. Stocker R; Keaney JF Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655 [TBL] [Abstract][Full Text] [Related]
20. [Role of protein carbamylation in chronic kidney disease complications]. Gillery P; Jaisson S; Gorisse L; Pietrement C Nephrol Ther; 2015 Jun; 11(3):129-34. PubMed ID: 25794932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]